Pharmabiz8m
Neurocrine Biosciences’ US FDA approved crinecerfont is available for children and adults to treat classic congenital adrenal hyperplasia
Neurocrine Biosciences’ US FDA approved crinecerfont is available for children and adults to treat classic congenital adrenal hyperplasia: San Diego Tuesday, December 24, 2024, ...
Pharmabiz1h
Karnataka having FDA is a good move in the interest of public health: Dr BR Jagashetty
Karnataka having FDA is a good move in the interest of public health: Dr BR Jagashetty: Nandita Vijayasimha, Bengaluru Tuesday, December 24, 2024, 08:00 Hrs [IST] Karnataka is pro ...
Pharmabiz1h
DGTR intensifies anti-dumping probe on import of PNT from European Union
DGTR intensifies anti-dumping probe on import of PNT from European Union: Shardul Nautiyal, Mumbai Tuesday, December 24, 2024, 08:00 Hrs [IST] In a bid to ensure transparency and ...
Pharmabiz1h
Natural remedies & lifestyle changes can effectively manage PCOS: Smita Naram
Natural remedies & lifestyle changes can effectively manage PCOS: Smita Naram: Shardul Nautiyal, Mumbai Tuesday, December 24, 2024, 08:00 Hrs [IST] Polycystic Ovary Syndrome (PCOS ...
Pharmabiz1h
NPPA mandates Serum Institute to continue manufacturing of TT injection one more year
NPPA mandates Serum Institute to continue manufacturing of TT injection one more year: Gireesh Babu, New Delhi Tuesday, December 24, 2024, 08:00 Hrs [IST] The National Pharmaceuti ...
Pharmabiz1h
Telangana pharma industry seeks clarity in certain provisions of Revised Schedule M
Telangana pharma industry seeks clarity in certain provisions of Revised Schedule M: Peethaambaran Kunnathoor, Chennai Tuesday, December 24, 2024, 08:00 Hrs [IST] The Telangana ph ...
Pharmabiz18h
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...
Pharmabiz15h
PeproMene Bio receives $11 million investment from IFLI to advance BAFF-R CAR T-cell therapy for relapsed/refractory follicular lymphoma
Irvine, California Monday, December 23, 2024, 18:00 Hrs [IST] ...
Pharmabiz18h
GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae
GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae: Our Bureau, Bengaluru Monday, December 23, 2024, 14 ...
Pharmabiz17h
US FDA approves Mesoblast’s mesenchymal stromal cell therapy, Ryoncil for steroid-refractory aGvHD in children 2 months and older
US FDA approves Mesoblast’s mesenchymal stromal cell therapy, Ryoncil for steroid-refractory aGvHD in children 2 months and older: Melbourne, Australia Monday, December 23, 2024 ...
Pharmabiz15h
Bhaskar Tare, director of Gloocal Communications, felicitated with Pride of Spandan Award 2024 for contribution in healthcare
Bhaskar Tare, director of Gloocal Communications, felicitated with Pride of Spandan Award 2024 for contribution in healthcare: Our Bureau, Mumbai Monday, December 23, 2024, 17:15 ...
Pharmabiz20h
Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101
Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101: Philadelphia Monday, December 23, 2024, 13:00 Hrs [IST] Vittoria Biotherapeutics, Inc, a clini ...